TXT Group, an international Global Digital Enabler providing engineering software solutions, recently announced raising $8,000,000 in funding. With a strong presence in high-tech markets, TXT Group has been guiding its customers through mission-critical processes since 1989. Listed on the Italian Stock Exchange's STAR segment, TXT Group's workforce now exceeds 1,000 skilled members. This funding round will further fuel the company's growth trajectory, allowing for expansion and enhancement of its service and product offerings. Headquartered in Milan, Italy, with a global presence across Europe and the USA, TXT Group continues to lead the digital revolution with its innovative approach.
TXT GROUP Secures $8 Million in Funding to Drive Digital Enabler Innovation Worldwide
Recently funded 路 $8.0MIT Services and IT Consulting
Get the full TXT GROUP company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
